Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 3/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31190448 | 0.90 | DGKA (0.58) | CNR2DGKACNR1MAPTELANE | |
| SCHEMBL25961085 | 0.90 | CNR2 (0.47) | CNR2DGKACNR1MAPTELANE | |
| SCHEMBL25961222 | 0.87 | CNR2 (0.48) | CNR2DGKACNR1MAPTELANE | |
| SCHEMBL10141503 | 0.86 | PTGS2 (0.60) | CNR2DGKACNR1ELANEPTGS2 | |
| SCHEMBL25969282 | 0.84 | CNR2 (0.50) | CNR2DGKACNR1ELANEGPR84 | |
| SCHEMBL12215158 | 0.80 | ELANE (0.55) | CNR2DGKACNR1MAPTELANE | |
| SCHEMBL27785221 | 0.77 | ALDH1A1 (0.58) | ALDH1A1 | |
| SCHEMBL16013406 | 0.77 | DNM1 (0.46) | CNR2DGKAMAPTELANELMNA | |
| SCHEMBL16012956 | 0.77 | DNM1 (0.46) | CNR2DGKAMAPTELANELMNA | |
| SCHEMBL28954693 | 0.77 | MAPT (0.59) | DGKAMAPTLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023144798-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2023-08-03 | — | — | WO | disclosed |